In a long-anticipated move, this past Wednesday GE spun out its healthcare division with a listing on the NASDAQ stock exchange. After […]
Posts Tagged ‘FDA’
Focus on Breast Density
At the beginning of this year, we wrote an article entitled “Understanding Breast Density,” and then in September we highlighted “World Dense Breast Day.” […]
DBT and AI – What a Combination!
Digital breast tomosynthesis (DBT) was approved by the FDA in 2011 as a screening modality for the early detection of […]
ABUS Firm Raises Another $30 Million
Delphinus Medical Technologies has just announced the closing of a $30 million investment to fast-track commercialisation of its SoftVue automated breast ultrasound […]
Invention and Entrepreneurship
David Albert is the founder and chief medical officer of AliveCor, a ten-year-old company whose vision is “to be the 24/7 virtual […]
Inspired by an Ancient Queen
A decade ago, Siddhartha Mukherjee published his prize-winning book entitled The Emperor of All Maladies: A Biography of Cancer. He quoted from […]
Is This Finally DBT’s Time?
Full-field digital mammography (FFDM) has been the “go to” imaging modality to screen for early detection of breast cancer for […]
Turning Cancer on Itself
Fifteen years ago, Samuel Mazin was a post-doctoral fellow at Stanford University, studying the inverse geometry of computer tomographic (CT) systems. He […]
Learning from Past Mistakes
Almost 25 years ago, in 1998, the FDA approved computer-aided detection (CAD) tools as an adjunct to mammography. This was before the […]
Angels in the Crowd
When an entrepreneur has a novel idea for a medical device, her biggest challenge will be to secure the necessary […]